Search results
Found 12089 matches for
Researchers at the University of Oxford led by DPAG's Professor Peter Robbins are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
Samira Lakhal-Littleton
Faculty
BSc DPhil Samira Lakhal-Littleton - Associate Professor of Cell Physiology and MRC Senior Non-Clinical Research Fellow
Charmaine Lang
Early Career Researchers Research Fellows Teaching and Education
Charmaine Lang - Kavli Institute Group Leader
Kerry Walker
Faculty Teaching and Education
DPhil, MSc, BSc Kerry Walker - Associate Professor of Neuroscience
Lisa Heather
Faculty Research Fellows Teaching and Education
Lisa Heather - BHF Intermediate Fellow and Associate Professor
Neil Herring
Faculty Research Fellows
DPhil, FRCP, FHRS Neil Herring - Professor of Cardiovascular Medicine, BHF Senior Fellow and Consultant Cardiologist
André Shamsabadi
Early Career Researchers Research Scientists
PhD André Shamsabadi - Post Doctoral Research Associate
Sebastien Callens
Research Fellows Research Scientists
PhD Sebastien Callens - UKRI Postdoctoral Research Fellow
Tanya Singh
Early Career Researchers OPDC Collaborators Research Scientists
Tanya Singh - Postdoctoral Research Scientist
Kaitlyn Cramb
Early Career Researchers OPDC Collaborators Research Scientists
Kaitlyn Cramb - Junior Research Fellow